| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.41 | 0.02 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.3 | 0.06 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.3 | 0.1 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.3 | 0.05 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.26 | 0.2 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.24 | 0.1 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.23 | 0.07 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.23 | 2e-05 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.21 | 0.3 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.21 | 0.2 |